Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab (Q40403631)
Jump to navigation
Jump to search
scientific article published on July 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab |
scientific article published on July 2005 |
Statements
1 reference
Dose-fractionated radioimmunotherapy in non-Hodgkin's lymphoma using DOTA-conjugated, 90Y-radiolabeled, humanized anti-CD22 monoclonal antibody, epratuzumab (English)
1 reference
Eva Cavallin-Ståhl
1 reference
Ola Lindén
1 reference
Cecilia Hindorf
1 reference
William A Wegener
1 reference
David M Goldenberg
1 reference
Heather Horne
1 reference
Tomas Ohlsson
1 reference
Lars Stenberg
1 reference
Sven-Erik Strand
1 reference
Jan Tennvall
1 reference
1 July 2005
1 reference
1 reference
11
1 reference
14
1 reference
5215-5222
1 reference
Identifiers
1 reference
1 reference